Anupma Nayak
Overview
Explore the profile of Anupma Nayak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
648
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Shah A, Lal P, Toorens E, Palmer M, Schwartz L, Vergara N, et al.
Am J Surg Pathol
. 2020 Jul;
44(11):1479-1486.
PMID: 32604168
Individuals with acquired cystic kidney disease (ACKD) in the setting of end-stage renal disease (ESRD) have a high risk of developing renal cell carcinoma (RCC). ACKD-RCC is considered a distinct...
22.
Gallagher E, Fei K, Feldman S, Port E, Friedman N, Boolbol S, et al.
Breast Cancer Res
. 2020 May;
22(1):40.
PMID: 32393319
Background: Racial disparities in breast cancer survival between Black and White women persist across all stages of breast cancer. The metabolic syndrome (MetS) of insulin resistance disproportionately affects more Black...
23.
Bleiweiss I, Nayak A
Breast J
. 2020 May;
26(6):1179-1184.
PMID: 32383293
Modern breast imaging techniques include digital mammography, 3-dimensional tomography, high-resolution ultrasound, and magnetic resonance imaging. Each of these has enabled the diagnosis of ever smaller, largely non-palpable lesions, not all...
24.
McDonald E, Doot R, Young A, Schubert E, Tchou J, Pryma D, et al.
J Nucl Med
. 2019 Dec;
61(5):665-670.
PMID: 31836680
The σ receptor is a potential in vivo target for measuring proliferative status in cancer. The feasibility of using -(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1)-yl)butyl)-2-(2-F-fluoroethoxy)-5-methylbenzamide (F-ISO-1) to image solid tumors in lymphoma, breast cancer, and...
25.
Khoury T, Fang Y, Karabakhtsian R, Desouki M, Nayak A, Hanna M, et al.
Breast J
. 2019 Oct;
26(2):197-205.
PMID: 31588665
The incidence of involved intramammary lymph node (intra-MLN) with breast carcinoma (BC) is rare. Its clinical significance and impact on the clinical decision making is unclear. A total of 113...
26.
Zou Y, Watters A, Cheng N, Perry C, Xu K, Alicea G, et al.
Cancer Discov
. 2019 Oct;
9(12):1720-1735.
PMID: 31578185
Brain metastasis, the most lethal form of melanoma and carcinoma, is the consequence of favorable interactions between the invading cancer cells and the brain cells. Peroxisome proliferator-activated receptor γ (PPARγ)...
27.
Lubin D, Toorens E, Zhang P, Jaffer S, Baraban E, Bleiweiss I, et al.
Am J Surg Pathol
. 2019 May;
43(7):1005-1013.
PMID: 31094929
Adenomyoepitheliomas (AME) of the breast and epithelial-myoepithelial carcinomas (EMCs) of salivary gland are morphologically similar tumors defined by the presence of a biphasic population of ductal epithelial elements mixed with...
28.
Damron A, Korhonen K, Zuckerman S, Tchou J, Dumoff K, Bleiweiss I, et al.
Int J Surg Pathol
. 2019 May;
27(7):781-787.
PMID: 31046496
Microglandular adenosis (MGA) of the breast is exceedingly rare, with only a few case reports and series published to date. Previous studies have elegantly demonstrated the progression of benign MGA...
29.
Jenkins T, Rosenbaum J, Zhang P, Schwartz L, Nayak A, Cooper K, et al.
Int J Surg Pathol
. 2019 Apr;
27(6):678-683.
PMID: 31032708
Thyroid-like follicular carcinoma of the kidney (TLFCK) is an extremely rare primary renal malignancy that typically has an indolent course and good prognosis. Histologically, this tumor mimics follicular carcinoma of...
30.
Wiens N, Hoffman D, Huang C, Nayak A, Tchou J
Am J Surg
. 2019 Apr;
219(4):651-654.
PMID: 30982573
Background: Breast adenomyoepithelioma (AME) is rare. We sought to evaluate clinical characteristics, treatment, and outcomes of a contemporary patient cohort stratified by histology. Methods: We queried health records containing "adenomyoepithelioma"...